Evidence map›Paper›PMID 36129706›Full record

ArticleJAMA network open2022

Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France.

Adeline Paumier, Antoine Asquier-Khati, Sonia Thibaut, Thomas Coeffic, Olivier Lemenand, Stéphanie Larramendy, Brice Leclère, Jocelyne Caillon, David Boutoille, Gabriel Birgand and 1 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Exploring multidrug resistance patterns in community-acquiredAntimicrobial agents and chemotherapy · 2025
    Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Investigating trends in antibiotic resistance ofMicrobiology (Reading, England) · 2024
    Article
  10. Article
  11. Antimicrobial Resistance Patterns in an Urban County: a Spatiotemporal Exploration.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Adeline PaumierCentre d'Appui à la Prévention des Infections Associées aux Soins des Pays de la Loire, Centre Hospitalier Universitaire (CHU)-Le Tourville, Nantes, France.
Antoine Asquier-KhatiCentre d'Appui à la Prévention des Infections Associées aux Soins des Pays de la Loire, Centre Hospitalier Universitaire (CHU)-Le Tourville, Nantes, France.
Sonia ThibautFrench National Surveillance System of Antimicrobial Resistance in Primary Care and Nursing Homes, PRIMO, CHU-Le Tourville, Nantes, France.
Thomas CoefficFrench National Surveillance System of Antimicrobial Resistance in Primary Care and Nursing Homes, PRIMO, CHU-Le Tourville, Nantes, France.
Olivier LemenandFrench National Surveillance System of Antimicrobial Resistance in Primary Care and Nursing Homes, PRIMO, CHU-Le Tourville, Nantes, France.
Stéphanie LarramendyDepartment of General Practice, Faculty of Medicine, University of Nantes, Nantes, France.
Brice LeclèreDepartment of Infectious Diseases, University Hospital of Nantes and Centre d'Investigation Clinique 1413, Institut National de la Santé et de la Recherche Médicale, Nantes, France.
Jocelyne CaillonFrench National Surveillance System of Antimicrobial Resistance in Primary Care and Nursing Homes, PRIMO, CHU-Le Tourville, Nantes, France.
David BoutoilleDepartment of Medical Evaluation and Epidemiology, CHU Nantes, Pays de la Loire, Nantes, France.
Gabriel BirgandCentre d'Appui à la Prévention des Infections Associées aux Soins des Pays de la Loire, Centre Hospitalier Universitaire (CHU)-Le Tourville, Nantes, France.
French Clinical Laboratories Nationwide Network
CNR de la Résistance aux Antibiotiques · FRNantes Université · FRNational Institute for Health Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is considered a leading pathogen contributing to the global burden of antimicrobial resistance. Objective: To better understand factors associated with the heterogeneity of community-acquired ESBL-producing E coli urinary tract infections (UTIs) in France. Design, Setting, and Participants: This cross-sectional study performed from January 1 to December 31, 2021, was based on data collected via PRIMO (Surveillance and Prevention of Antimicrobial Resistance in Primary Care and Nursing Homes), a nationwide clinical laboratory surveillance system in France. Strains of E coli isolated from community urine samples from January 1 to December 31, 2019, from 59 administrative departments of metropolitan France were included. Main Outcomes and Measures: Quasi-Poisson regression models were used to assess the associations between several ecological factors available on government and administration websites between 2010 and 2020 (demographic population structure, living conditions, baseline health care services, antibiotic consumptions, economic indicators, animal farming density, and environmental characteristics) and the number of ESBL-producing E coli strains isolated from urine samples of individuals with community-acquired UTI in 2019. Results: Among 444 281 E coli isolates from urine samples tested in 1013 laboratories, the mean prevalence of ESBL-producing E coli was 3.0% (range, 1.4%-8.8%). In an adjusted model, the number of community-acquired ESBL-producing E coli UTIs in each department was positively associated with the percentage of children younger than 5 years (adjusted β1 coefficient, 0.112 [95% CI, 0.040-0.185]; P = .004), overcrowded households (adjusted β1 coefficient, 0.049 [95% CI, 0.034 to 0.062]; P < .001), consumption of fluoroquinolones (adjusted β1 coefficient, 0.002 [95% CI, 0.001-0.002]; P < .001), and tetracyclines (adjusted β1 coefficient, 0.0002 [0.00004 to 0.00039]; P = .02), and poultry density (adjusted β1 coefficient, 0.0001 [95% CI, 0.0001-0.0002]; P < .001). The social deprivation index (adjusted β1 coefficient, -0.115 [95% CI, -0.165 to -0.064]; P < .001) and the proportion of water surface area (adjusted β1 coefficient, -0.052 [-0.081 to -0.024]; P = .001) were negatively associated with a higher number of community-acquired ESBL-producing E coli UTIs. Conclusions and Relevance: The findings of this cross-sectional study suggest that multiple human health, animal health, and environmental factors are associated with the occurence of community-acquired ESBL E coli UTI. Strategies to mitigate ESBL in the community should follow the One Health approach and address the role played by fluoroquinolones, tetracycline use, poultry density, overcrowded households, and preschool-aged children.

Indexed as

Community-Acquired InfectionsEscherichia coli InfectionsUrinary Tract InfectionsAnimalsAnti-Bacterial Agentsbeta-LactamasesChildChild, PreschoolCross-Sectional StudiesEscherichia coliFluoroquinolonesHumansTetracyclineWaterAnti-Bacterial Agentsbeta-LactamasesFluoroquinolonesTetracyclineWater

Identifiers

PMID36129706
PMCPMC9494187
OpenAlexW4296809354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.